Free tool
FAERS Monitor: Aciphex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020973 or its brand name (Aciphex, Rabeprazole Sodium). Reports on generic versions are filed under their own applications.
Reports
27,290
Serious
21,997
81% of reports
Hospitalization
8,769
Death reported
3,391
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- chronic kidney disease4,878
- renal failure3,417
- acute kidney injury2,629
- nausea1,646
- drug ineffective1,579
- end stage renal disease1,310
- diarrhoea1,203
- dyspnoea1,196
- pain1,189
- headache1,130
- death1,128
- tubulointerstitial nephritis1,122
- fatigue1,063
- dizziness1,023
- arthralgia975
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,025 |
| 2005 | 1,068 |
| 2006 | 1,064 |
| 2007 | 958 |
| 2008 | 1,000 |
| 2009 | 914 |
| 2010 | 1,179 |
| 2011 | 1,674 |
| 2012 | 1,874 |
| 2013 | 663 |
| 2014 | 602 |
| 2015 | 712 |
| 2016 | 745 |
| 2017 | 654 |
| 2018 | 5,997 |
| 2019 | 1,359 |
| 2020 | 726 |
| 2021 | 888 |
| 2022 | 1,122 |
| 2023 | 945 |
| 2024 | 892 |
| 2025 | 736 |
| 2026 | 492 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,026,869 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| end stage renal diseaseSignal | 1,310 | 59.6 | 56.4 | 70,019 |
| chronic kidney diseaseSignal | 4,878 | 52.8 | 51.4 | 232,800 |
| tubulointerstitial nephritisSignal | 1,122 | 49.0 | 46.2 | 49,612 |
| renal failureSignal | 3,417 | 20.3 | 19.7 | 61,552 |
| acute kidney injurySignal | 2,629 | 13.5 | 13.0 | 29,994 |
| arthralgia | 975 | 1.8 | 1.7 | 358 |
| dyspnoea | 1,196 | 1.6 | 1.5 | 298 |
| nausea | 1,646 | 1.6 | 1.5 | 388 |
| dizziness | 1,023 | 1.6 | 1.5 | 223 |
| pain | 1,189 | 1.5 | 1.4 | 198 |
| diarrhoea | 1,203 | 1.4 | 1.4 | 164 |
| headache | 1,130 | 1.4 | 1.3 | 127 |
| fatigue | 1,063 | 1.1 | 1.0 | 3 |
| death | 1,128 | 1.0 | 1.0 | 0 |
| drug ineffective | 1,579 | 0.9 | 0.9 | 11 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.